Rothschild Capital Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
1,030
+193
+23% +$197K 0.26% 39
2026
Q1
$770K Sell
837
-677
-45% -$686K 0.19% 48
2025
Q4
$1.63M Buy
1,514
+300
+25% +$287K 0.38% 30
2025
Q3
$926K Hold
1,214
0.22% 32
2025
Q2
$946K Hold
1,214
0.25% 29
2025
Q1
$1M Buy
1,214
+230
+23% +$191K 0.26% 30
2024
Q4
$760K Buy
+984
New +$815K 0.18% 36

Other funds holding LLY

Rothschild Capital Partners's LLY Position: Q2 2026 in Review

Rothschild Capital Partners increased its Eli Lilly (LLY) stake by 23% in Q2 2026, buying an estimated $197K and bringing the position to 1,030 shares worth $1.24M. The position accounts for 0.26% of the portfolio, ranked #39.

Rothschild Capital Partners first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.63M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Rothschild Capital Partners held 1,030 shares of Eli Lilly worth $1.24M as of Q2 2026.
  • Rothschild Capital Partners bought 193 Eli Lilly shares in Q2 2026, an estimated $197K.
  • Eli Lilly made up 0.26% of Rothschild Capital Partners's portfolio in Q2 2026, its #39 holding.
  • Rothschild Capital Partners first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • Rothschild Capital Partners's Eli Lilly position peaked at $1.63M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Rothschild Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.